FPS
BLUE

Fieldpoint Private Securities’s bluebird bio BLUE Stock Holding History

Fieldpoint Private Securities’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-89
Closed -$50K – 1567
2020
Q4 		$50K Buy
+89
New +$56.4K 0.01% 475
2020
Q1 		– Sell
-193
Closed -$218K – 283
2019
Q4 		$218K Buy
193
+119
+161% +$129K 0.06% 255
2019
Q3 		$88K Sell
74
-7
-9% -$10.7K 0.03% 312
2019
Q2 		$133K Buy
+81
New +$140K 0.04% 284

Other funds holding BLUE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Fieldpoint Private Securities's BLUE Position: Q1 2021 in Review

Fieldpoint Private Securities sold out of bluebird bio (BLUE) in Q1 2021, closing a stake of 89 shares — an estimated $50K sold.

Fieldpoint Private Securities first reported a position in BLUE in Q2 2019 and held it in 4 quarters. The position peaked at $218K in Q4 2019. 229 funds tracked by Wall St. Rank hold BLUE as of Q1 2021.

  • Fieldpoint Private Securities reported no remaining bluebird bio position as of Q1 2021 after selling out during the quarter.
  • Fieldpoint Private Securities sold 89 bluebird bio shares in Q1 2021, an estimated $50K.
  • Fieldpoint Private Securities first reported a position in bluebird bio in Q2 2019 and held it in 4 quarters.
  • Fieldpoint Private Securities's bluebird bio position peaked at $218K in Q4 2019.
  • 229 funds tracked by Wall St. Rank held bluebird bio as of Q1 2021.

Based on Fieldpoint Private Securities's 13F filing for Q1 2021, filed 23 Apr 2021.